Bladder cancer: a review of non-muscle invasive disease.
about
A healthy bladder: a consensus statementImmunotherapy in urothelial carcinoma: fade or future standard?MicroRNAs as biomarkers associated with bladder cancer.Genitourinary oncology: current status and future challenges.Examining sexual dysfunction in non-muscle-invasive bladder cancer: results of cross-sectional mixed-methods research.Models of inflammation of the lower urinary tract.Evaluation of miR-141, miR-200c, miR-30b Expression and Clinicopathological Features of Bladder Cancer.Educational opportunities in bladder cancer: increasing cystoscopic adherence and the availability of smoking-cessation programsFractionated intravesical radioimmunotherapy with (213)Bi-anti-EGFR-MAb is effective without toxic side-effects in a nude mouse model of advanced human bladder carcinoma.Normalization of gene expression measurement of tissue samples obtained by transurethral resection of bladder tumorsSex differences in the physiology and pharmacology of the lower urinary tract.Efficient intravesical therapy of bladder cancer with cationic doxorubicin nanoassemblies.Induction of invasive transitional cell bladder carcinoma in immune intact human MUC1 transgenic mice: a model for immunotherapy development.Alterations of histone H1 phosphorylation during bladder carcinogenesisThe Recombinant Bacille Calmette-Guérin Vaccine VPM1002: Ready for Clinical Efficacy Testing.Eight-plex iTRAQ labeling and quantitative proteomic analysis for human bladder cancer.DCAMKL1 is associated with the malignant status and poor outcome in bladder cancer.
P2860
Q26863299-30B85019-BB2F-415C-8513-58BF1ABE66D7Q28078284-F788CBD1-DD8C-4CF6-AEFE-2922E8ADF32CQ33642335-91FD98D2-3029-4E0B-B7B6-1CB3606A76F1Q34278266-56361FF0-C586-459E-9448-C81254B15BD4Q34286211-A0D3326F-EDEF-4AE2-9544-F74291C6B5C6Q35041139-CBB0EBDF-C5A3-45F0-8BAC-B0B78E93E72EQ35177639-084AD76A-02CA-4B2F-A17F-98761955EF6FQ35545878-3BF52DFA-3FC8-47A9-B808-E53CA8A915B5Q36838996-ADC26813-74F2-4E8E-9DC0-92A8F565F374Q36982267-D226BCD0-9BFD-4751-9C0D-C7179E474FFDQ37198062-F286943B-CAD4-405B-8E97-E25C6C71C454Q37249063-6F78517F-3B83-4BF7-893A-714252B1901CQ37662390-437559A0-B483-49EC-AC2F-BE73C98A30D0Q39151691-E5A715CF-0D7F-4B5C-B237-DC4F01D7779FQ41836016-3405AFAD-DFB0-44D9-9952-6CE7B59E7D1AQ41963590-1CA5F523-DABF-49C0-9238-11BC8B24DE6FQ50941345-5D60CAD0-6DC3-4940-8E41-ACDACF37A189
P2860
Bladder cancer: a review of non-muscle invasive disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Bladder cancer: a review of non-muscle invasive disease.
@en
Bladder cancer: a review of non-muscle invasive disease.
@nl
type
label
Bladder cancer: a review of non-muscle invasive disease.
@en
Bladder cancer: a review of non-muscle invasive disease.
@nl
prefLabel
Bladder cancer: a review of non-muscle invasive disease.
@en
Bladder cancer: a review of non-muscle invasive disease.
@nl
P2093
P2860
P1433
P1476
Bladder cancer: a review of non-muscle invasive disease.
@en
P2093
Christos Politis
José J Correa
Loveleen C Kang
Lucas R Wiegand
Shohreh Iravani Dickinson
Wade J Sexton
P2860
P304
P356
10.1177/107327481001700406
P577
2010-10-01T00:00:00Z